2,075 results match your criteria Expert Review of Cardiovascular Therapy[Journal]


Cardiac arrhythmias secondary to hormone therapy in trans women.

Expert Rev Cardiovasc Ther 2019 Apr 15. Epub 2019 Apr 15.

b Division of Cardiology, Kingston Health Science Center , Queen's University , Kingston , Ontario , Canada.

Introduction: With greater social acceptance and the evolution of transgender medicine as a specialty, more trans women are seeking hormone therapy (HT). Several studies have identified an increase in cardiovascular disease in trans women, however no studies have investigated the incidence of arrhythmias. Using two cases from the authors' clinic as examples, we propose that hormone therapy in trans women may increase the risk of cardiac arrhythmias. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1606713DOI Listing
April 2019
2 Reads

Spontaneous coronary artery dissection: a review of complications and management strategies.

Expert Rev Cardiovasc Ther 2019 Apr 8;17(4):275-291. Epub 2019 Apr 8.

a Division of Cardiology , Vancouver General Hospital , Vancouver , BC , Canada.

Introduction: Spontaneous coronary artery dissection (SCAD) accounts for up to 4% of acute coronary syndromes (ACS) on coronary angiography and predominantly affects women (>90%). SCAD most often occurs in patients with few or no conventional cardiovascular risk factors. This condition remains underdiagnosed due to a lack of awareness among health-care providers and misdiagnosis on coronary angiography. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1598261DOI Listing
April 2019
5 Reads

Developing a disease management program for the improvement of heart failure outcomes: the do's and the don'ts.

Expert Rev Cardiovasc Ther 2019 Apr 8;17(4):267-273. Epub 2019 Apr 8.

a Healthcare Group , St. Vincent's University Hospital , Dublin , Ireland.

Introduction: Heart failure is a highly prevalent condition affecting approximately 2% of people worldwide. Heart failure disease management programs (DMP) have shown a reduction in mortality and reduced hospitalization and are an established part of clinical guidelines; however, their presence is not widespread. Focusing on the application of proven therapies, patient education, diagnosis with work up of cause and easy access for clinical deterioration should be fundamental to the structure of the DMP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1596798DOI Listing
April 2019
2 Reads

Utility of the cold pressor test to predict future cardiovascular events.

Expert Rev Cardiovasc Ther 2019 Apr 8;17(4):305-318. Epub 2019 Apr 8.

i Department of Surgery , Virinchi Hospitals , Hyderbad , India.

Introduction: The cold pressor test (CPT) is a common and extensively validated test, which induces systemic stress involving immersion of an individual's hand in ice water (normally temperature between 0 and 5 degrees Celsius) for a period of time. CPT has been used in various fields, like examining effects of stress on memory, decision-making, pain and cardiovascular health. Areas covered: In terms of cardiovascular health, current research is mainly interested in predicting the occurrence of cardiovascular (CV) events. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1598262DOI Listing
April 2019
2 Reads

To test, or not to test: that is the question for the future of lipoprotein(a).

Expert Rev Cardiovasc Ther 2019 Apr 3;17(4):241-250. Epub 2019 Apr 3.

b School of Medicine, Faculty of Medicine and Health Sciences , University of Western Australia , Perth , Australia.

Introduction: Lipoprotein(a) [Lp(a)] is a potent, highly heritable and common risk factor for atherosclerotic cardiovascular disease (ASCVD). Evidence for a causal association between elevated Lp(a) and ASCVD has been provided by large epidemiological investigations that have demonstrated a curvilinear association with increased risk, as well as from genetic examinations and cellular and transgenic animal studies. Although there are several therapies available for lowering Lp(a), none are selective for Lp(a) and there is no clinical trial data that has specifically shown that lowering Lp(a) reduces the risk of ASCVD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1596799DOI Listing
April 2019
1 Read

Transcatheter aortic valve replacement and cardiac conduction.

Expert Rev Cardiovasc Ther 2019 Apr;17(4):293-304

a The Christ Hospital Heart and Vascular Center , Cincinnati , OH , USA.

Introduction: Conduction abnormalities after transcatheter aortic valve replacement (TAVR) account for a high percentage of post-TAVR complications. Areas covered: The etiology of conduction abnormalities is closely tied to cardiac anatomy (length of membranous septum, degree of calcification, location of left bundle within the membranous septum), baseline conduction abnormalities (preprocedure right bundle branch block), and procedural variables (type of valve, depth of implant). Management of new high-grade AV block and new left bundle branch block varies by institution in the absence of consensus guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1598264DOI Listing
April 2019
2 Reads

Edoxaban for the prevention of stroke in patients with atrial fibrillation.

Expert Rev Cardiovasc Ther 2019 Apr 27;17(4):319-330. Epub 2019 Mar 27.

b Cardiology Department , Hospital Ramón y Cajal , Madrid , Spain.

Introduction: Edoxaban is the last direct oral anticoagulant marketed for the prevention of stroke among patients with nonvalvular atrial fibrillation (AF). Areas covered: ENGAGE AF-TIMI 48 was the pivotal clinical trial that led to the approval of edoxaban 60 mg once daily. After the publication of this study, a great number of substudies and post hoc analyses have been published, together with some observational studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1598263DOI Listing
April 2019
4 Reads

Exercise and sports participation in patients with thoracic aortic disease: a review.

Expert Rev Cardiovasc Ther 2019 Apr 21;17(4):251-266. Epub 2019 Mar 21.

a Department of Cardiology , Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands.

Introduction: Current guidelines recommend patients with thoracic aortic disease (TAD) including inherited aortopathies to avoid heavy exercise. However, evidence supporting the negative advice on exercise is scarce. We aimed to provide an up-to-date systematic review of the available evidence on risks and benefits of exercise and sports participation in TAD patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1585807DOI Listing
April 2019
3 Reads

Should all diabetic patients take statin therapy regardless of serum cholesterol level?

Expert Rev Cardiovasc Ther 2019 Apr 11;17(4):237-239. Epub 2019 Mar 11.

a Detroit Medical Center, Detroit Heart Hospital , Wayne State University , Detroit , MI , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1590198DOI Listing
April 2019
1 Read

Intracardiac multimorbidity: assessing right ventricular function in left-sided heart failure through cardiopulmonary exercise testing.

Expert Rev Cardiovasc Ther 2019 Feb 21:1-3. Epub 2019 Feb 21.

a Department of Physical Therapy, College of Applied Health Sciences , University of Illinois at Chicago , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1585808DOI Listing
February 2019
1 Read

Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management.

Expert Rev Cardiovasc Ther 2019 Mar 20;17(3):209-223. Epub 2019 Feb 20.

h Bariatric & Metabolic Surgery Clinic , Kirloskar Hospital , Hyderabad , India.

Introduction: Obesity, defined as a Body Mass Index (BMI) of ≥30 kg/m2, is the most common chronic metabolic disease worldwide and its prevalence has been strongly increasing. Obesity is associated with various diseases such as cardiovascular disease, type 2 diabetes, and hypertension. Regarding heart rhythm disorders, obesity is associated with an increase in atrial fibrillation (AF), the most common arrhythmia in clinical practice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1581064DOI Listing
March 2019
1 Read

eHealth to improve patient outcome in rehabilitating myocardial infarction patients.

Expert Rev Cardiovasc Ther 2019 Mar 19;17(3):185-192. Epub 2019 Feb 19.

a Department of Cardiology , Leiden University Medical Center , Leiden , The Netherlands.

Introduction: Cardiac rehabilitation is aimed at risk factor modification and improving quality of life. eHealth has a couple of potential benefits to improve this aim. The primary purpose of this review is to summarize available literature for eHealth strategies that have been investigated in randomized controlled trials in post-myocardial infarction (MI) patients. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1580570DOI Listing
March 2019
8 Reads

Update on Bayés' syndrome: the association between an interatrial block and supraventricular arrhythmias.

Expert Rev Cardiovasc Ther 2019 Mar 6;17(3):225-235. Epub 2019 Feb 6.

a Department of Cardiology , Instituto Cardiovascular de Buenos Aires , Buenos Aires , Argentina.

Introduction: The past few years have given rise to extensive research on an interatrial block and its clinical relevance, mainly its association with supraventricular arrhythmias. In 2015, the authors of this article reviewed the Bayes syndrome for the first time and after three years there has been so much evidence accumulated that it seems reasonable to rewrite an update, based fundamentally on the new findings. Focused on its relationship with cardioembolic strokes, today efforts are being targeted at understanding its pathophysiology, its diagnosis, and its prognostic implications, in order to learn if it should be treated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1577137DOI Listing
March 2019
2 Reads

The link between anemia and adverse outcomes in patients with acute coronary syndrome.

Expert Rev Cardiovasc Ther 2019 Mar 19;17(3):151-159. Epub 2019 Feb 19.

a The Zena and Michael A. Weiner Cardiovascular Institute , The Icahn School of Medicine at Mount Sinai , New York , USA.

Introduction: Anemia is one of the most frequent comorbidities in acute coronary syndrome (ACS) patients and is associated with a significant impact on clinical outcomes. This review summarizes the knowledge and updated management of anemia in the setting of ACS. Areas covered: We provide a review on the prevalence, pathophysiology, prognosis, impact, and updated management of anemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1575729DOI Listing
March 2019
1 Read

Diagnosis and treatment of pediatric pulmonary arterial hypertension.

Expert Rev Cardiovasc Ther 2019 Mar 12;17(3):161-175. Epub 2019 Feb 12.

a Pediatric Cardiology Unit , University Children's Hospital of Geneva , Geneva , Switzerland.

Introduction: Pediatric pulmonary arterial hypertension (PAH) remains a rare and severe disease with a poor prognosis. PAH may be idiopathic, heritable or associated with systemic conditions in particular associated with congenital heart disease. Areas covered: A thorough and extensive diagnostic approach is required for a correct diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1576523DOI Listing
March 2019
1 Read

Percutaneous pericardial access for electrophysiological studies in patients with prior cardiac surgery: approach and understanding the risks.

Expert Rev Cardiovasc Ther 2019 Feb 29;17(2):143-150. Epub 2018 Dec 29.

a Department of Cardiovascular Disease, Division of Heart Rhythm Services , Mayo Clinic , Rochester , MN , USA.

Introduction: The number of procedures for which percutaneous pericardial access is used for has gradually increased since its initial description, and now includes mapping/ablation, atrial appendage ligation and pericardial biopsy. Areas covered: Successful percutaneous pericardial access is predicated on having a thorough understanding of regional anatomy, indications for attempting pericardial puncture and potential complications with appropriate management which are highlighted in this review. In addition, we will discuss the access technique itself, provide tips and pitfalls and highlight future directions with an emphasis on patients with prior cardiac surgery. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1561276DOI Listing
February 2019
6 Reads

Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.

Expert Rev Cardiovasc Ther 2019 Mar 9;17(3):177-184. Epub 2019 Jan 9.

a Department of Clinical and Translational Science , Creighton University School of Medicine , Omaha , NE , USA.

Introduction: Despite advances in drug eluting technologies, neointimal hyperplasia (NIH) and restenosis still plagues endovascular therapy in atherosclerotic diseases. By appreciating atherosclerosis and NIH as complex inflammatory processes, specialized pro-resolving mediators (SPMs) are a superfamily of endogenous unsaturated fatty-acid derived lipids with the potential for inflammatory resolution. Areas covered: Inquiry into SPMs in this context is a novel approach and is the focus of this review, with emphasis on our understanding with NIH. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1563483DOI Listing
March 2019
14 Reads

Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Expert Rev Cardiovasc Ther 2019 Mar 29;17(3):193-207. Epub 2018 Dec 29.

a Department of Clinical and Translational Science , Creighton University School of Medicine , Omaha , NE , USA.

Introduction: Recurrent atrial fibrillation (RAF) following ablation therapy occurs in about 50% of patients. The pathogenesis of RAF is unknown, but is believed to be driven by atrial remodeling in the setting of background inflammation. Structural, electrophysiological and mechanical remodeling has been associated with atrial fibrillation (AF). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1562902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386629PMC
March 2019
12 Reads

Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities.

Expert Rev Cardiovasc Ther 2019 Feb 31;17(2):95-109. Epub 2018 Dec 31.

b Rudolfstiftung Hospital , Danube University Krems , Vienna , Austria.

Introduction: When >3 trabeculations associated with interventricular recesses are found, this is termed 'left ventricular hypertrabeculation/noncompaction' (LVHT). Cardiac-imaging methods detect LVHT in all ages, isolated or associated with extracardiac, especially neuromuscular disorders (NMDs). Many issues about LVHT are unclear. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1561280DOI Listing
February 2019
3 Reads

Rating of perceived exertion on resistance training in elderly subjects.

Expert Rev Cardiovasc Ther 2019 Feb 7;17(2):135-142. Epub 2019 Jan 7.

a Institute for Human Movement and Medical Sciences , Niigata University of Health and Welfare , Niigata , Japan.

Introduction: The American College of Sports Medicine and American Heart Association recommends resistance training involving 60-70% of 1-repetition maximum (1RM) for 8-12 repetitions on 2 or 3 nonconsecutive days per week for the elderly. The Borg 6-20 scale, Borg category ratio (CR-10) scale, and OMNI scale are used to determine the rating of perceived exertion (RPE) for resistance training. Areas covered: RPE scales for resistance training performed by elderly individuals are described. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1561278DOI Listing
February 2019
1 Read

Gender differences in the clinical features and outcomes of patients with coronary artery disease.

Expert Rev Cardiovasc Ther 2019 Feb 29;17(2):127-133. Epub 2018 Dec 29.

b Department of Cardiovascular Medicine , Juntendo University Graduate School of Medicine , Tokyo , Japan.

Introduction: Women have been at a higher risk for adverse cardiac events following percutaneous coronary intervention (PCI), compared with men. Areas covered: In this review, authors discuss the gender differences that can affect the clinical outcomes after PCI and the important points that can be improved on. Expert commentary: Various factors, such as old age and higher prevalence of comorbidities, have been considered to account for the worse clinical outcomes of PCI in women than in men. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1561277DOI Listing
February 2019
26 Reads

Assessing and managing coronary microcirculation dysfunction in acute ST-segment elevation myocardial infarction.

Expert Rev Cardiovasc Ther 2019 Feb 31;17(2):111-126. Epub 2018 Dec 31.

b Oxford Heart Centre, John Radcliffe Hospital , Oxford University Hospitals , Oxford , UK.

Introduction: Microvascular dysfunction in the setting of acute ST-segment elevation myocardial infarction (STEMI) is an indicator of poor long-term prognosis. Prompt assessment and pharmacological or procedural therapy (prophylactic or post onset of dysfunction) may improve outcomes in STEMI post-primary percutaneous intervention. Areas covered: The aim of this review is to provide a comprehensive analysis of the evidence available about the assessment and management of coronary microcirculatory injury/dysfunction in STEMI. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1561279DOI Listing
February 2019
14 Reads

Link between coffee and atrial fibrillation debunked?

Expert Rev Cardiovasc Ther 2018 Dec 4. Epub 2018 Dec 4.

a Department of Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine , University of Modena and Reggio Emilia , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1556096DOI Listing
December 2018
2 Reads

Clinical management in the takotsubo syndrome.

Expert Rev Cardiovasc Ther 2018 Dec 4. Epub 2018 Dec 4.

a Department of Cardiology , Sahlgrenska University Hospital , Gothenburg Sweden.

Introduction: Takotsubo syndrome (TS) is an increasingly recognized acute heart failure syndrome which is self-limiting in most cases but can result in life-threatening complications. TS is difficult to distinguish from acute myocardial infarction (AMI) early in the disease course and currently lacks evidence-based treatment recommendations. Areas covered: Based on the available literature this systematic review discusses the clinical management of patients with TS during (i) the diagnostic workup; (ii) acutely after establishing the TS diagnosis; and (iii) after recovery of cardiac function. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1556098DOI Listing
December 2018
17 Reads

Getting patients with cardiovascular disease to move more: cardiac rehabilitation and beyond.

Expert Rev Cardiovasc Ther 2019 02 10;17(2):79-81. Epub 2018 Dec 10.

a Department of Physical Therapy , College of Applied Health Sciences, University of Illinois at Chicago , Chicago , IL , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1556097DOI Listing
February 2019
4 Reads

Mitral valve prolapse.

Expert Rev Cardiovasc Ther 2018 Nov 28. Epub 2018 Nov 28.

a Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust , London , UK.

Introduction: Mitral valve prolapse is a common valve pathology with a spectrum of disease from isolated prolapse to myxomatous, multi-scallop Barlow's disease. The main complications relate to progression of mitral regurgitation, endocarditis, sudden death and stroke. The timing of intervention in patients with asymptomatic severe mitral regurgitation is controversial. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1553619DOI Listing
November 2018
8 Reads

Exercise as a therapeutic approach to improve blood pressure in patients with peripheral arterial disease: current literature and future directions.

Expert Rev Cardiovasc Ther 2018 Nov 27. Epub 2018 Nov 27.

b Hospital Israelita Albert Einstein , SaoPaulo-SP , Brazil.

Introduction: Patients with symptomatic peripheral artery disease (PAD) exhibit reduced functional capacity and increased mortality due to cardiovascular disease. Although exercise has been a cornerstone for clinical treatment to improve walking capacity in patients with symptomatic PAD, its effects on cardiovascular parameters have been poorly explored. Areas covered: This review examines the role of exercise in improving blood pressure in patients with symptomatic PAD and summarizes the current evidence on the acute (single bout of exercise) and chronic effects of walking and resistance exercise on blood pressure and its determinants. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1553676DOI Listing
November 2018
3 Reads

Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation?

Expert Rev Cardiovasc Ther 2019 Jan 18;17(1):31-41. Epub 2018 Dec 18.

a Department of Cardiology , Montefiore Medical Center, Albert Einstein College of Medicine , Bronx , NY , USA.

Introduction: Atrial fibrillation is the most common arrhythmia worldwide. Its increasing prevalence has made the use of oral anticoagulants for stroke prevention routine; however, their use after the blanking period of catheter ablation remains uncertain. Areas covered: This review outlines the pros and cons of stopping oral anticoagulation after catheter ablation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1550718DOI Listing
January 2019
5 Reads

How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension.

Expert Rev Cardiovasc Ther 2019 Jan 6;17(1):11-18. Epub 2018 Dec 6.

a Cardiology Department, AHEPA University Hospital , Aristotle University of Thessaloniki , Thessaloniki , Greece.

Introduction: Patients with congenital heart disease (CHD), who develop pulmonary arterial hypertension (PAH), live longer, and have better quality of life compared to the past due to PAH-specific therapy and improved tertiary care. Areas covered: Clinical examination, objective assessment of functional capacity, natriuretic peptide levels, cardiac imaging, and hemodynamics all play a pivotal role in the evaluation, general care, and management of PAH-specific therapy. This review discusses the epidemiology and pathophysiology of PAH-CHD and provides hints for the optimal evaluation of these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1550716DOI Listing
January 2019
21 Reads

Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques.

Expert Rev Cardiovasc Ther 2019 Jan 26;17(1):53-63. Epub 2018 Nov 26.

a Cardiovascular Department , Università degli Studi di Trieste , Trieste , Italy.

Introduction: Dilated cardiomyopathy (DCM) is generally thought as a final common pathway of several conditions leading to the same clinical phenotype. Multiple imaging modalities play a fundamental role in recognizing the underlying pathological substrate in DCM. Areas covered: Echocardiography represents the first reliable and easily accessible diagnostic tool, allowing the identification of associated cardiac abnormalities, such as valve disease and highlighting features associated with an adverse prognosis. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1550719DOI Listing
January 2019
17 Reads

Organizing stroke systems in the field for patients with suspected large vessel occlusion acute stroke.

Expert Rev Cardiovasc Ther 2018 Nov 19:1-7. Epub 2018 Nov 19.

a Department of Clinical Neurosciences , Cumming School of Medicine, University of Calgary , Calgary , Canada.

Introduction: The dawn of endovascular stroke therapy has reshaped stroke care. Eligible patients need to be rushed to capable centers for intervention. This may entail bypassing closer hospitals that could confirm the diagnosis, administer thrombolytic therapy, then transfer patients for intervention. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1550717DOI Listing
November 2018
13 Reads

Determining the best approach to reduce the impact of exercise-induced atrial fibrillation: prevention, screening, or symptom-based treatment?

Expert Rev Cardiovasc Ther 2018 Nov 19. Epub 2018 Nov 19.

a Arrhythmia Unit, Hospital Clinic, Universitat de Barcelona , Barcelona , Catalonia , Spain.

Introduction: Regular endurance exercise over the course of many years appears to increase the risk of atrial fibrillation (AF). These data challenge the notion that the benefits of physical activity have no appreciable limits. The incidence of exercise-induced AF is expected to increase as a consequence of the popularity of extreme endurance sports. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2019.1550720DOI Listing
November 2018
9 Reads

Pulmonary arterial hypertension: assessing risk to improve prognosis.

Expert Rev Cardiovasc Ther 2018 Nov 13:1-2. Epub 2018 Nov 13.

d Department of Clinical Sciences Lund , Cardiology, Lund University, and Skåne University Hospital , Lund , Sweden.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2019.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2019.1548278DOI Listing
November 2018
15 Reads

Neurological complications associated with left ventricular assist device therapy.

Expert Rev Cardiovasc Ther 2018 Dec 13;16(12):909-917. Epub 2018 Nov 13.

c Division of Cardiovascular Surgery , University of Minnesota , Minneapolis , MN , USA.

Introduction: Associated with significant morbidity and mortality, neurological complications in adult patients with left ventricular assist devices (LVAD) approaches a prevalence as high as 25%. As the number of individuals using LVAD support grows, it is increasingly important for providers to understand the hematologic and hemodynamic changes associated with LVAD implantation, the risk factors for neurological complications and their mitigation strategies. Areas covered: PubMed searches were completed using the terms 'Left ventricular assist device and stroke' (994 results) then 'Left ventricular assist device and stroke risk factors' (199 results). Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1540300DOI Listing
December 2018
19 Reads

Radiation and the heart: systematic review of dosimetry and cardiac endpoints.

Expert Rev Cardiovasc Ther 2018 Dec 1;16(12):931-950. Epub 2018 Nov 1.

b Mayo Clinic - Department of Cardio-Oncology , Scottsdale , AZ , USA.

Introduction: Recent trials in radiotherapy have associated heart dose and survival, inadequately explained by the existing literature for radiation-related late cardiac effects.  Authors aimed to review the recent literature on cardiac dosimetry and survival/cardiac endpoints. Areas covered: Systematic review of the literature in the past 10 years (2008-2017) was performed to identify manuscripts reporting both cardiac dosimetry and survival/cardiac endpoints. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1538785DOI Listing
December 2018
31 Reads

Lowering the systolic blood pressure target in hypertensive patients: current controversies and future outlook.

Expert Rev Cardiovasc Ther 2018 Dec 25;16(12):889-895. Epub 2018 Oct 25.

a Division of Cardiovascular Medicine, Department of Medicine , Jichi Medical University School of Medicine , Tochigi , Japan.

Introduction: Randomized controlled trials and meta-analyses have established the benefits of blood pressure (BP) lowering. The 2017 American Heart Association/American College of Cardiology (AHA/ACC) guidelines for the management of hypertension established 130/80 mmHg as the threshold for the diagnosis- and treatment-target BP level. Area covered: The global trends are thought to be heading toward intensive BP-lowering management. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1538784DOI Listing
December 2018
11 Reads

Pathophysiology of essential hypertension: an update.

Expert Rev Cardiovasc Ther 2018 Dec;16(12):879-887

b Department Yoga and Physical education , Mittal Hospital and Research Centre , Ajmer , India.

Introduction: Hypertension is caused by increased cardiac output and/or increased peripheral resistance. Areas covered: The various mechanisms affecting cardiac output/peripheral resistance involved in the development of essential hypertension are covered. These include genetics; sympathetic nervous system overactivity; renal mechanisms: excess sodium intake and pressure natriuresis; vascular mechanisms: endothelial cell dysfunction and the nitric oxide pathway; hormonal mechanisms: the renin-angiotensin-aldosterone system (RAAS); obesity, obstructive sleep apnea (OSA); insulin resistance and metabolic syndrome; uric acid; vitamin D; gender differences; racial, ethnic, and environmental factors; increased left ventricular ejection force and hypertension and its association with increased basal sympathetic activity - cortical connections. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1540301DOI Listing
December 2018
40 Reads

Functional assessment of coronary stenosis: an overview of available techniques. Is quantitative flow ratio a step to the future?

Expert Rev Cardiovasc Ther 2018 Dec 1;16(12):951-962. Epub 2018 Nov 1.

a Division of Clinical Cardiology , A.O.R.N. Sant'Anna e San Sebastiano , Caserta , Italy.

Introduction: The assessment of coronary lesions severity has always been a relevant topic in the management of the patient undergoing coronary angiography. Fractional flow reserve (FFR) has been introduced as an objective index to determine the significance of a coronary stenosis with a positive impact on clinical outcomes has been demonstrated for FFR-guided coronary interventions. However, several technical drawbacks have been pointed out in clinical practice limiting the diffusion of FFR worldwide. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2018.1540303DOI Listing
December 2018
4 Reads

Targeting sudden death in heart failure with preserved ejection fraction: promise or pipedream?

Expert Rev Cardiovasc Ther 2018 12 29;16(12):875-877. Epub 2018 Oct 29.

b Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2018.1540302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363355PMC
December 2018
1 Read

FFR derived from computed tomography angiography: the experience in the UK.

Expert Rev Cardiovasc Ther 2018 Dec 25;16(12):919-929. Epub 2018 Oct 25.

a The Royal London Hospital and St Bartholomew's Hospital, London, Barts Health NHS Trust , London , UK.

Introduction: Non-invasive fractional flow reserve derived from CT coronary angiography (FFR) represents a novel technology to investigate coronary artery disease. The application of computational flow dynamics to anatomical data provides the clinician with a further functional assessment to inform decision-making in patients with coronary artery disease. In the UK FFR has received medical technology approval for use since February 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2018.1538786DOI Listing
December 2018
11 Reads

Expecting the unexpected: preventing and managing the consequences of coronary perforations.

Expert Rev Cardiovasc Ther 2018 Nov 19;16(11):805-814. Epub 2018 Oct 19.

a Minneapolis Heart Institute , Abbott Northwestern Hospital , Minneapolis , MN , USA.

Introduction: Coronary artery perforations are more likely to occur during percutaneous coronary intervention of complex coronary lesions, such as heavily calcified lesions and chronic total occlusions. Areas covered: Authors provide an update on the management of coronary perforations by performing a critical review of the related, recently published literature. Expert commentary: Meticulous attention to guidewire position and to device selection is critical for minimizing the risk for coronary perforation. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1533402DOI Listing
November 2018
17 Reads

Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease.

Expert Rev Cardiovasc Ther 2018 Nov 16;16(11):825-835. Epub 2018 Oct 16.

a The Icahn School of Medicine at Mount Sinai , The Zena and Michael A. Wiener Cardiovascular Institute , New York , New York , USA.

Introduction: Chronic kidney disease (CKD) is commonly present in patients undergoing percutaneous coronary intervention (PCI). These patients frequently present with more complex coronary artery disease (CAD) and higher risk of peri-procedural and post-procedural adverse events, including bleeding, thrombotic events, and contrast-induced acute kidney injury (CI-AKI). This article contains updated knowledge and management of patients with CKD undergoing PCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14779072.2018.1526082DOI Listing
November 2018
2 Reads

Managing complications of hypertension in aortic valve stenosis patients.

Expert Rev Cardiovasc Ther 2018 Dec 19;16(12):897-907. Epub 2018 Oct 19.

b Department of Clinical Science , University of Bergen , Bergen , Norway.

Introduction: Hypertension is highly prevalent in aortic valve stenosis (AS) patients as the prevalence of both disorders increases with age. Hypertension and associated stiffening of the large arteries increase afterload and thereby influence both the transvalvular flow and the remodeling of the aortic root and the left ventricle during AS progression. Area covered: The present review gives an overview on complications of hypertension in AS, how these can be diagnosed, and potentially may be managed. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1535899DOI Listing
December 2018
19 Reads

Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism.

Expert Rev Cardiovasc Ther 2018 Nov 15;16(11):845-855. Epub 2018 Oct 15.

a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.

Introduction: Compared to other direct oral anticoagulants, betrixaban has a longer half-life, smaller peak-trough variance, minimal renal clearance, and minimal hepatic Cytochrome P (CYP) metabolism. The Acute Medically Ill VTE Prevention with Extended Duration Betrixaban (APEX) trial evaluated the efficacy and safety of extended duration betrixaban compared to standard duration enoxaparin in acutely ill hospitalized patients. Areas covered: This article describes the role of betrixaban in the prevention of venous thromboembolism (VTE) in acutely ill medical patients. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1534068DOI Listing
November 2018
26 Reads

Optimal medical treatment of hypertension in patients with coronary artery disease.

Expert Rev Cardiovasc Ther 2018 Nov 16;16(11):815-823. Epub 2018 Oct 16.

b Division of Cardiovascular Medicine , University of Florida , Gainesville , FL , USA.

Introduction: Coronary artery disease (CAD) remains the leading cause of mortality and morbidity worldwide, and hypertension is its most prevalent modifiable risk factor. Patients with CAD and concomitant hypertension are a special population with distinct physiologic and structural alterations. Optimal blood pressure (BP) control in this population has been linked with reduction in adverse outcomes, however, excessive lowering of BP could jeopardize myocardial and cerebral perfusion. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1534069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380682PMC
November 2018
10 Reads

Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives.

Expert Rev Cardiovasc Ther 2018 11 11;16(11):771-773. Epub 2018 Oct 11.

a Cardiovascular Department , Azienda Sanitaria-Universitaria Integrata of Trieste (ASUITS) , Trieste , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1533815DOI Listing
November 2018
18 Reads

Relationship between P-wave duration and the risk of atrial fibrillation.

Expert Rev Cardiovasc Ther 2018 Nov 11;16(11):837-843. Epub 2018 Oct 11.

b Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and Prevention, and Department of Medicine, Section on Cardiology , Wake Forest School of Medicine , Winston Salem , NC , USA.

Introduction: P-wave duration (PWD) is an electrocardiographic (ECG) marker reflecting atrial conduction, and studies have shown that its prolongation is associated with atrial fibrillation. Areas covered: This review addresses the relationship between PWD and atrial fibrillation, how anatomic and physiologic changes in the atria potentiate the risk for atrial fibrillation, and how these atrial anatomic and physiologic changes relate to PWD. Other P-wave related entities, such as P-wave terminal force in V1, PR interval, and P wave axis are also addressed. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1533814DOI Listing
November 2018
5 Reads

Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review.

Expert Rev Cardiovasc Ther 2018 Nov 15;16(11):857-873. Epub 2018 Oct 15.

a Department of Cardiology , Aalborg University Hospital , Aalborg , Denmark.

Background: Atrial fibrillation (AF) is a growing epidemic and evidence of a relationship to socioeconomic status (SES) is inconsistent. We aimed to summarize the literature about SES and AF and defined two objectives: (1) To examine the association between SES and the risk of AF; (2) To examine the association between SES and AF-related outcomes in an AF-population.

Methods: We performed a separate search for each objective in Ovid-MEDLINE and Ovid-Embase. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1533118DOI Listing
November 2018
27 Reads

Stress echocardiography in valvular heart disease.

Expert Rev Cardiovasc Ther 2018 Nov 10;16(11):795-804. Epub 2018 Oct 10.

a Echocardiography Laboratory , Barts Heart Centre, St Bartholomew's Hospital , London , UK.

Introduction: The management of patients with heart valve disease can be complex. Patients may have symptoms disproportionate to the severity or the severity may be unclear. In addition, the optimal timing of intervention in patients with severe disease may be controversial. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1532791DOI Listing
November 2018
3 Reads

Relationship between intra-operative vein graft treatment with DuraGraft® or saline and clinical outcomes after coronary artery bypass grafting.

Expert Rev Cardiovasc Ther 2018 Dec 14;16(12):963-970. Epub 2018 Oct 14.

f Division of Aging , Brigham and Women's Hospital , Boston , MA , USA.

Background: Saphenous vein grafts (SVGs) remain the most often used conduits for coronary bypass grafting (CABG). Progressive intimal hyperplasia contributes to vein-graft disease and vein-graft failure (VGF). We compared the impact of intraoperative preservation of SVGs in a storage solution (DuraGraft®) versus heparinized saline on VGF-related outcomes after CABG. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14779072.2018.1
Publisher Site
http://dx.doi.org/10.1080/14779072.2018.1532289DOI Listing
December 2018
15 Reads